In the Feb 26 issue of Science, the Chief Patent Counsel for GlaxoSmithKline has written a "Policy Forum" article outlining the reasons that the pharmaceutical industry needs longer and stronger patent protection on its new drugs (to fend off those nasty generics). I was kind of shocked to see such a propaganda piece in Science, but I suppose it is all part of looking at both (all) sides of an issue.